Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 258

1.

Implementation and impact of pediatric antimicrobial stewardship programs: a systematic scoping review.

Donà D, Barbieri E, Daverio M, Lundin R, Giaquinto C, Zaoutis T, Sharland M.

Antimicrob Resist Infect Control. 2020 Jan 3;9:3. doi: 10.1186/s13756-019-0659-3. eCollection 2020. Review.

2.

Length of stay, cost, and mortality of healthcare-acquired bloodstream infections in children and neonates: A systematic review and meta-analysis.

Karagiannidou S, Triantafyllou C, Zaoutis TE, Papaevangelou V, Maniadakis N, Kourlaba G.

Infect Control Hosp Epidemiol. 2020 Jan 3:1-13. doi: 10.1017/ice.2019.353. [Epub ahead of print]

PMID:
31898557
3.

Standardising neonatal and paediatric antibiotic clinical trial design and conduct: the PENTA-ID network view.

Folgori L, Lutsar I, Standing JF, Walker AS, Roilides E, Zaoutis TE, Jafri H, Giaquinto C, Turner MA, Sharland M.

BMJ Open. 2019 Dec 31;9(12):e032592. doi: 10.1136/bmjopen-2019-032592.

4.

Readmissions after hospital care for meningitis in the United States.

Ellis DE, Zaoutis T, Thibault DP, Crispo JAG, Abraham DS, Willis AW.

Am J Infect Control. 2019 Dec 17. pii: S0196-6553(19)30954-X. doi: 10.1016/j.ajic.2019.10.025. [Epub ahead of print]

PMID:
31862168
5.

Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium.

Donnelly JP, Chen SC, Kauffman CA, Steinbach WJ, Baddley JW, Verweij PE, Clancy CJ, Wingard JR, Lockhart SR, Groll AH, Sorrell TC, Bassetti M, Akan H, Alexander BD, Andes D, Azoulay E, Bialek R, Bradsher RW, Bretagne S, Calandra T, Caliendo AM, Castagnola E, Cruciani M, Cuenca-Estrella M, Decker CF, Desai SR, Fisher B, Harrison T, Heussel CP, Jensen HE, Kibbler CC, Kontoyiannis DP, Kullberg BJ, Lagrou K, Lamoth F, Lehrnbecher T, Loeffler J, Lortholary O, Maertens J, Marchetti O, Marr KA, Masur H, Meis JF, Morrisey CO, Nucci M, Ostrosky-Zeichner L, Pagano L, Patterson TF, Perfect JR, Racil Z, Roilides E, Ruhnke M, Prokop CS, Shoham S, Slavin MA, Stevens DA, Thompson GR, Vazquez JA, Viscoli C, Walsh TJ, Warris A, Wheat LJ, White PL, Zaoutis TE, Pappas PG.

Clin Infect Dis. 2019 Dec 5. pii: ciz1008. doi: 10.1093/cid/ciz1008. [Epub ahead of print]

PMID:
31802125
6.

Influence of national culture and context on healthcare workers' perceptions of infection prevention in Greek neonatal intensive care units.

Triantafillou V, Kopsidas I, Kyriakousi A, Zaoutis TE, Szymczak JE.

J Hosp Infect. 2019 Nov 29. pii: S0195-6701(19)30490-6. doi: 10.1016/j.jhin.2019.11.020. [Epub ahead of print]

PMID:
31790745
7.

Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium.

Cornely OA, Alastruey-Izquierdo A, Arenz D, Chen SCA, Dannaoui E, Hochhegger B, Hoenigl M, Jensen HE, Lagrou K, Lewis RE, Mellinghoff SC, Mer M, Pana ZD, Seidel D, Sheppard DC, Wahba R, Akova M, Alanio A, Al-Hatmi AMS, Arikan-Akdagli S, Badali H, Ben-Ami R, Bonifaz A, Bretagne S, Castagnola E, Chayakulkeeree M, Colombo AL, Corzo-León DE, Drgona L, Groll AH, Guinea J, Heussel CP, Ibrahim AS, Kanj SS, Klimko N, Lackner M, Lamoth F, Lanternier F, Lass-Floerl C, Lee DG, Lehrnbecher T, Lmimouni BE, Mares M, Maschmeyer G, Meis JF, Meletiadis J, Morrissey CO, Nucci M, Oladele R, Pagano L, Pasqualotto A, Patel A, Racil Z, Richardson M, Roilides E, Ruhnke M, Seyedmousavi S, Sidharthan N, Singh N, Sinko J, Skiada A, Slavin M, Soman R, Spellberg B, Steinbach W, Tan BH, Ullmann AJ, Vehreschild JJ, Vehreschild MJGT, Walsh TJ, White PL, Wiederhold NP, Zaoutis T, Chakrabarti A; Mucormycosis ECMM MSG Global Guideline Writing Group.

Lancet Infect Dis. 2019 Dec;19(12):e405-e421. doi: 10.1016/S1473-3099(19)30312-3. Epub 2019 Nov 5. Review.

PMID:
31699664
8.

Effect of Caspofungin vs Fluconazole Prophylaxis on Invasive Fungal Disease Among Children and Young Adults With Acute Myeloid Leukemia: A Randomized Clinical Trial.

Fisher BT, Zaoutis T, Dvorak CC, Nieder M, Zerr D, Wingard JR, Callahan C, Villaluna D, Chen L, Dang H, Esbenshade AJ, Alexander S, Wiley JM, Sung L.

JAMA. 2019 Nov 5;322(17):1673-1681. doi: 10.1001/jama.2019.15702.

PMID:
31688884
9.

2-Year Outcomes After Complete or Staged Procedure for Tetralogy of Fallot in Neonates.

Savla JJ, Faerber JA, Huang YV, Zaoutis T, Goldmuntz E, Kawut SM, Mercer-Rosa L.

J Am Coll Cardiol. 2019 Sep 24;74(12):1570-1579. doi: 10.1016/j.jacc.2019.05.057.

PMID:
31537267
10.

The timing and redosing of perioperative antimicrobial prophylaxis in Greek children.

Dimopoulou A, Kourlaba G, Psarris A, Lourida A, Coffin S, Spoulou V, Zaoutis T.

Infect Control Hosp Epidemiol. 2019 Nov;40(11):1318-1319. doi: 10.1017/ice.2019.244. Epub 2019 Sep 17. No abstract available.

PMID:
31526403
11.

Antibiotic treatment and antimicrobial resistance in children with urinary tract infections.

Vazouras K, Velali K, Tassiou I, Anastasiou-Katsiardani A, Athanasopoulou K, Barbouni A, Jackson C, Folgori L, Zaoutis T, Basmaci R, Hsia Y.

J Glob Antimicrob Resist. 2019 Jun 25;20:4-10. doi: 10.1016/j.jgar.2019.06.016. [Epub ahead of print]

PMID:
31252156
12.

A prospective study on the epidemiology and clinical significance of viral respiratory infections among pediatric oncology patients.

Vliora C, Papadakis V, Doganis D, Tourkantoni N, Paisiou A, Kottaridi C, Kourlamba G, Zaoutis T, Kosmidis H, Kattamis A, Polychronopoulou S, Goussetis E, Giannouli G, Syridou G, Priftis K, Papaevangelou V.

Pediatr Hematol Oncol. 2019 Apr;36(3):173-186. doi: 10.1080/08880018.2019.1613462. Epub 2019 Jun 19.

PMID:
31215284
13.

Education, decision support, feedback and a minor reward: a novel antimicrobial Stewardship intervention in a Swedish paediatric emergency setting.

Malmgren A, Biswanger K, Lundqvist A, Zaoutis T.

Infect Dis (Lond). 2019 Aug;51(8):559-569. doi: 10.1080/23744235.2019.1606933. Epub 2019 May 15.

PMID:
31088317
14.

Authors' Response.

Puopolo KM, Benitz WE, Zaoutis TE.

Pediatrics. 2019 May;143(5). pii: e20190533B. doi: 10.1542/peds.2019-0533B. No abstract available.

PMID:
31040198
15.

Effects of an antimicrobial stewardship intervention on perioperative antibiotic prophylaxis in pediatrics.

Donà D, Luise D, La Pergola E, Montemezzo G, Frigo A, Lundin R, Zaoutis T, Gamba P, Giaquinto C.

Antimicrob Resist Infect Control. 2019 Jan 15;8:13. doi: 10.1186/s13756-019-0464-z. eCollection 2019.

16.

Attributable length of stay and cost for pediatric and neonatal central line-associated bloodstream infections in Greece.

Karagiannidou S, Zaoutis T, Maniadakis N, Papaevangelou V, Kourlaba G.

J Infect Public Health. 2019 May - Jun;12(3):372-379. doi: 10.1016/j.jiph.2018.12.004. Epub 2019 Jan 4.

17.

Diagnosis and Management of Pediatric Influenza in the Era of Rapid Diagnostics.

Kitt E, Drew RJ, Cunney R, Beekmann SE, Polgreen P, Butler K, Zaoutis T, Coffin SE.

J Pediatric Infect Dis Soc. 2018 Nov 22. doi: 10.1093/jpids/piy118. [Epub ahead of print]

PMID:
30476135
18.

Management of Neonates Born at ≤34 6/7 Weeks' Gestation With Suspected or Proven Early-Onset Bacterial Sepsis.

Puopolo KM, Benitz WE, Zaoutis TE; COMMITTEE ON FETUS AND NEWBORN; COMMITTEE ON INFECTIOUS DISEASES.

Pediatrics. 2018 Dec;142(6). pii: e20182896. doi: 10.1542/peds.2018-2896. Review.

19.

Management of Neonates Born at ≥35 0/7 Weeks' Gestation With Suspected or Proven Early-Onset Bacterial Sepsis.

Puopolo KM, Benitz WE, Zaoutis TE; COMMITTEE ON FETUS AND NEWBORN; COMMITTEE ON INFECTIOUS DISEASES.

Pediatrics. 2018 Dec;142(6). pii: e20182894. doi: 10.1542/peds.2018-2894. Review.

20.

Posaconazole Administration in Hospitalized Children in the United States.

Lavigne S, Fisher BT, Ellis D, Zaoutis TE, Downes KJ.

J Pediatric Infect Dis Soc. 2019 Nov 6;8(5):481-484. doi: 10.1093/jpids/piy119.

PMID:
30445549
21.

Variation in Outpatient Antibiotic Dispensing for Respiratory Infections in Children by Clinician Specialty and Treatment Setting.

Agiro A, Gautam S, Wall E, Hackell J, Helm M, Barron J, Zaoutis T, Fleming-Dutra KE, Hicks LA, Rosenberg A.

Pediatr Infect Dis J. 2018 Dec;37(12):1248-1254. doi: 10.1097/INF.0000000000002004.

PMID:
30408006
22.

Increased 30-Day Mortality Associated With Carbapenem-Resistant Enterobacteriaceae in Children.

Chiotos K, Tamma PD, Flett KB, Karandikar MV, Nemati K, Bilker WB, Zaoutis T, Han JH.

Open Forum Infect Dis. 2018 Sep 10;5(10):ofy222. doi: 10.1093/ofid/ofy222. eCollection 2018 Oct.

23.

Antibiotics and Cure Rates in Childhood Febrile Urinary Tract Infections in Clinical Trials: A Systematic Review and Meta-analysis.

Vazouras K, Basmaci R, Bielicki J, Folgori L, Zaoutis T, Sharland M, Hsia Y.

Drugs. 2018 Oct;78(15):1593-1604. doi: 10.1007/s40265-018-0988-1.

24.

The use of echinocandins in hospitalized children in the United States.

Downes KJ, Ellis D, Lavigne S, Bryan M, Zaoutis TE, Fisher BT.

Med Mycol. 2018 Sep 28. doi: 10.1093/mmy/myy084. [Epub ahead of print]

PMID:
30265325
25.

Treatment of extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBLs) infections: what have we learned until now?

Pana ZD, Zaoutis T.

F1000Res. 2018 Aug 29;7. pii: F1000 Faculty Rev-1347. doi: 10.12688/f1000research.14822.1. eCollection 2018. Review.

26.

Surveillance for central-line-associated bloodstream infections: Accuracy of different sampling strategies.

Kourkouni E, Kourlaba G, Chorianopoulou E, Tsopela GC, Kopsidas I, Spyridaki I, Tsiodras S, Roilides E, Coffin S, Zaoutis TE; PHIG investigators.

Infect Control Hosp Epidemiol. 2018 Oct;39(10):1210-1215. doi: 10.1017/ice.2018.187. Epub 2018 Aug 29.

PMID:
30156182
27.

Editor's Note.

Zaoutis TE.

J Pediatric Infect Dis Soc. 2018 Aug 17;7(3):177. doi: 10.1093/jpids/piy074. No abstract available.

PMID:
30124932
28.

Epidemiology of infections and antimicrobial use in Greek Neonatal Units.

Gkentzi D, Kortsalioudaki C, Cailes BC, Zaoutis T, Kopsidas J, Tsolia M, Spyridis N, Siahanidou S, Sarafidis K, Heath PT, Dimitriou G; Neonatal Infection Surveillance Network in Greece.

Arch Dis Child Fetal Neonatal Ed. 2019 May;104(3):F293-F297. doi: 10.1136/archdischild-2018-315024. Epub 2018 Jun 28.

PMID:
29954881
29.

Multifaceted but Invisible: Perceptions of the Value of a Pediatric Cognitive Specialty.

Szymczak JE, Lee G, Klieger SB, Woods C, Creech CB, Gilsdorf JR, Dennehy P, Zaoutis T.

Hosp Pediatr. 2018 Jul;8(7):385-393. doi: 10.1542/hpeds.2017-0240.

30.

Candidemia in children: Epidemiology, prevention and management.

Mantadakis E, Pana ZD, Zaoutis T.

Mycoses. 2018 Sep;61(9):614-622. doi: 10.1111/myc.12792. Epub 2018 May 31. Review.

PMID:
29762868
31.

The Impact of Clinical Pathways on Antibiotic Prescribing for Acute Otitis Media and Pharyngitis in the Emergency Department.

Dona D, Baraldi M, Brigadoi G, Lundin R, Perilongo G, Hamdy RF, Zaoutis T, Da Dalt L, Giaquinto C.

Pediatr Infect Dis J. 2018 Sep;37(9):901-907. doi: 10.1097/INF.0000000000001976.

PMID:
29561517
32.

Effects of clinical pathway implementation on antibiotic prescriptions for pediatric community-acquired pneumonia.

Donà D, Zingarella S, Gastaldi A, Lundin R, Perilongo G, Frigo AC, Hamdy RF, Zaoutis T, Da Dalt L, Giaquinto C.

PLoS One. 2018 Feb 28;13(2):e0193581. doi: 10.1371/journal.pone.0193581. eCollection 2018.

33.

Association of Broad- vs Narrow-Spectrum Antibiotics With Treatment Failure, Adverse Events, and Quality of Life in Children With Acute Respiratory Tract Infections.

Gerber JS, Ross RK, Bryan M, Localio AR, Szymczak JE, Wasserman R, Barkman D, Odeniyi F, Conaboy K, Bell L, Zaoutis TE, Fiks AG.

JAMA. 2017 Dec 19;318(23):2325-2336. doi: 10.1001/jama.2017.18715.

34.

Urinary Tract Infection Antibiotic Trial Study Design: A Systematic Review.

Basmaci R, Vazouras K, Bielicki J, Folgori L, Hsia Y, Zaoutis T, Sharland M.

Pediatrics. 2017 Dec;140(6). pii: e20172209. doi: 10.1542/peds.2017-2209. Review.

35.

Invasive Fungal Disease in Pediatric Solid Organ Transplant Recipients.

Saxena S, Gee J, Klieger S, Kajon A, Petersen H, Zaoutis T, Fisher B.

J Pediatric Infect Dis Soc. 2018 Aug 17;7(3):219-225. doi: 10.1093/jpids/pix041.

36.

Association of Acute Kidney Injury With Concomitant Vancomycin and Piperacillin/Tazobactam Treatment Among Hospitalized Children.

Downes KJ, Cowden C, Laskin BL, Huang YS, Gong W, Bryan M, Fisher BT, Goldstein SL, Zaoutis TE.

JAMA Pediatr. 2017 Dec 4;171(12):e173219. doi: 10.1001/jamapediatrics.2017.3219. Epub 2017 Dec 4.

37.

Multicenter Study of the Risk Factors for Colonization or Infection with Carbapenem-Resistant Enterobacteriaceae in Children.

Chiotos K, Tamma PD, Flett KB, Naumann M, Karandikar MV, Bilker WB, Zaoutis T, Han JH.

Antimicrob Agents Chemother. 2017 Nov 22;61(12). pii: e01440-17. doi: 10.1128/AAC.01440-17. Print 2017 Dec.

38.

Epidemiology of Invasive Fungal Disease in Children.

Pana ZD, Roilides E, Warris A, Groll AH, Zaoutis T.

J Pediatric Infect Dis Soc. 2017 Sep 1;6(suppl_1):S3-S11. doi: 10.1093/jpids/pix046. Review.

39.

Bone and Joint Infections.

Saavedra-Lozano J, Falup-Pecurariu O, Faust SN, Girschick H, Hartwig N, Kaplan S, Lorrot M, Mantadakis E, Peltola H, Rojo P, Zaoutis T, LeMair A.

Pediatr Infect Dis J. 2017 Aug;36(8):788-799. doi: 10.1097/INF.0000000000001635. No abstract available.

PMID:
28708801
40.

Risk Factors for Invasive Fungal Disease in Pediatric Cancer and Hematopoietic Stem Cell Transplantation: A Systematic Review.

Fisher BT, Robinson PD, Lehrnbecher T, Steinbach WJ, Zaoutis TE, Phillips B, Sung L.

J Pediatric Infect Dis Soc. 2018 Aug 17;7(3):191-198. doi: 10.1093/jpids/pix030. Review.

41.

Guideline for the Management of Fever and Neutropenia in Children With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: 2017 Update.

Lehrnbecher T, Robinson P, Fisher B, Alexander S, Ammann RA, Beauchemin M, Carlesse F, Groll AH, Haeusler GM, Santolaya M, Steinbach WJ, Castagnola E, Davis BL, Dupuis LL, Gaur AH, Tissing WJE, Zaoutis T, Phillips R, Sung L.

J Clin Oncol. 2017 Jun 20;35(18):2082-2094. doi: 10.1200/JCO.2016.71.7017. Epub 2017 May 1. Review.

PMID:
28459614
42.

High fluoroquinolone MIC is associated with fluoroquinolone treatment failure in urinary tract infections caused by fluoroquinolone susceptible Escherichia coli.

Rattanaumpawan P, Nachamkin I, Bilker WB, Roy JA, Metlay JP, Zaoutis TE, Lautenbach E; CDC prevention epicenters program.

Ann Clin Microbiol Antimicrob. 2017 Apr 8;16(1):25. doi: 10.1186/s12941-017-0202-4.

43.

The Role of Stewardship in Addressing Antibacterial Resistance: Stewardship and Infection Control Committee of the Antibacterial Resistance Leadership Group.

Anderson DJ, Jenkins TC, Evans SR, Harris AD, Weinstein RA, Tamma PD, Han JH, Banerjee R, Patel R, Zaoutis T, Lautenbach E; Stewardship and Infection Control Committeea of the Antibacterial Resistance Leadership Group (ARLG).

Clin Infect Dis. 2017 Mar 15;64(suppl_1):S36-S40. doi: 10.1093/cid/ciw830. Review.

44.

Infant Colonization With Methicillin-Resistant Staphylococcus aureus or Vancomycin-Resistant Enterococci Preceding Neonatal Intensive Care Unit Discharge.

Clock SA, Jia H, Patel S, Ferng YH, Alba L, Whittier S, DeLaMora P, Tabibi S, Perlman J, Paul D, Zaoutis T, Larson E, Saiman L.

J Pediatric Infect Dis Soc. 2017 Sep 1;6(3):e144-e148. doi: 10.1093/jpids/pix003.

45.

The Molecular and Clinical Epidemiology of Extended-Spectrum Cephalosporin- and Carbapenem-Resistant Enterobacteriaceae at 4 US Pediatric Hospitals.

Zerr DM, Weissman SJ, Zhou C, Kronman MP, Adler AL, Berry JE, Rayar J, Myers J, Haaland WL, Burnham CD, Elward A, Newland J, Selvarangan R, Sullivan KV, Zaoutis T, Qin X.

J Pediatric Infect Dis Soc. 2017 Nov 24;6(4):366-375. doi: 10.1093/jpids/piw076.

46.

Antibiotic Prophylaxis Is Associated with Subsequent Resistant Infections in Children with an Initial Extended-Spectrum-Cephalosporin-Resistant Enterobacteriaceae Infection.

Das S, Adler AL, Miles-Jay A, Kronman MP, Qin X, Weissman SJ, Burnham CA, Elward A, Newland JG, Selvarangan R, Sullivan KV, Zaoutis T, Zerr DM.

Antimicrob Agents Chemother. 2017 Apr 24;61(5). pii: e02656-16. doi: 10.1128/AAC.02656-16. Print 2017 May.

47.

Variability in Antibiotic Prescribing for Community-Acquired Pneumonia.

Handy LK, Bryan M, Gerber JS, Zaoutis T, Feemster KA.

Pediatrics. 2017 Apr;139(4). pii: e20162331. doi: 10.1542/peds.2016-2331. Epub 2017 Mar 7.

48.

Factors associated with persistent colonisation with methicillin-resistant Staphylococcus aureus.

Cluzet VC, Gerber JS, Nachamkin I, Coffin SE, Davis MF, Julian KG, Zaoutis TE, Metlay JP, Linkin DR, Tolomeo P, Wise JA, Bilker WB, Hu B, Lautenbach E; CDC PREVENTION EPICENTERS PROGRAM.

Epidemiol Infect. 2017 May;145(7):1409-1417. doi: 10.1017/S0950268817000012. Epub 2017 Feb 21.

PMID:
28219463
49.

Azithromycin Prophylaxis for Laboring Mothers.

Gerber JS, Zaoutis TE.

Pediatrics. 2017 Feb;139(2). pii: e20163643. doi: 10.1542/peds.2016-3643. No abstract available.

50.

A Computerized Sexual Health Survey Improves Testing for Sexually Transmitted Infection in a Pediatric Emergency Department.

Goyal MK, Fein JA, Badolato GM, Shea JA, Trent ME, Teach SJ, Zaoutis TE, Chamberlain JM.

J Pediatr. 2017 Apr;183:147-152.e1. doi: 10.1016/j.jpeds.2016.12.045. Epub 2017 Jan 10.

Supplemental Content

Loading ...
Support Center